Comet Therapeutics - Ownership and Business Overview

Life ScienceCompany

Comet Therapeutics Ownership

Who owns Comet Therapeutics?

Comet Therapeutics is owned by VectivBio AG. It was acquired on August 31, 2021.

Comet Therapeutics Business Overview

Where is Comet Therapeutics headquartered?

Comet Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Comet Therapeutics in?

Comet Therapeutics is a life science company.

When was Comet Therapeutics founded?

Comet Therapeutics was founded in 2018.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 389 acquisitions of life science companies in 2021, including 45 acquisitions by private equity firms, and 344 by strategics.

Comet Therapeutics

Comet Therapeutics, Inc.

610 Main St,
Cambridge, Massachusetts 02139
United States,
www.comettherapeutics.com

Comet Therapeutics is a privately held company that has been developing drugs to address previously untreatable Inherited Metabolic Diseases. Comet Therapeutics was formed in 2018 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.